WHO

Pharma Courses 
PAGE Admission
  • Career for M.Pharm as Consultant at World Health Organization
    8 April 2025

    Career for M.Pharm as Consultant at World Health Organization

    To contribute to the development of AMR curriculum assessment tools for pharmacy and nursing education; and to support youth engagement and AMR awareness-raising activities.
  • 8 October 2024
    WHO adds an HPV vaccine for single-dose use
    WHO announced that a fourth WHO-prequalified human papillomavirus vaccine product, Cecolin has been confirmed for use in a single-dose schedule. The decision is made based on new data on the product that fulfilled the criteria set out in the WHO 2022 recommendations for alternative, off-label use of HPV vaccines in single-dose schedules.
  • 15 August 2024
    WHO Director-General declares mpox outbreak a public health emergency of international concern
    WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo and a growing number of countries in Africa constitutes a public health emergency of international concern under the International Health Regulations.
  • 16 May 2024
    WHO prequalifies new dengue vaccine
    WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission intensity. The vaccine should be administered in a 2-dose schedule with a 3-month interval between doses.
  • 11 March 2024
    WHO launches new manual to support delivery of psychological interventions

    By providing practical guidance on how to implement psychological interventions, this guide will help increase access to evidence-based interventions so that more people can benefit from them. The manual focuses on evidence-based psychological intervention manuals delivered by a non-specialist workforce.

  • 11 January 2024
    WHO lanuches ICD-11, Traditional Medicine Module 2

    With the launch of ICD 11, Traditional Medicine Module 2 by the World Health Organization today, preparations have started for its implementation. The data and terminology relating to diseases based on Ayurveda, Siddha and Unani Medicine have been included in the WHO ICD-11 classification. With this effort, the terminology defining diseases in Ayurveda, Unani and Siddha medicine has been indexed as a code and included in the WHO Disease Classification Series ICD-11.

  • 3 October 2023
    Job opportunity for Research Associate to work in WHO TDR Project RMRC, Ph.D or M.Pharm Apply

    The ICMR-Regional Medical Research Centre, Bhubaneswar is a permanent research centre of Indian Council of Medical Research. The foundation stone of the centre was laid by the then prime minister of India Late Mrs. Indira Gandhi on 29th March 1981.Initially the Center started in a small rental accommodation in 1982 and shifted to the Centre’s own building in year 1990 after completion.

  • 3 October 2023
    Work as Technical Officer at WHO India

    WHO India Country Office collaborates with the Government of India and relevant stakeholders within the framework of the collaborative Country Cooperation Strategy (CCS), to actively support the development and implementation of national health policies, strategies and plans aiming at promoting access to and utilization of affordable and quality health services and improving financial protection against health-related risks.

  • 26 July 2023
    Opportunity for M.Pharm or MSc to Join THSTI-WHO Program - Pay Rs. 66,000 pm

    Translational Health Science and Technology Institute (THSTI) is an autonomous Institute of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India. The institute is an integral part of the interdisciplinary NCR Biotech Science Cluster located at Faridabad, and is designed as a dynamic, interactive organization with the mission to conductinnovative translational research and to develop research collaborations across disciplines and professions to translate concepts into products to improve human health.

  • 25 July 2023
    WHO releases new guidance to improve testing and diagnosis of sexually transmitted infections

    The World Health Organization (WHO) is sharing its latest guidance on sexually transmitted infections (STI) at the STI & HIV 2023 World Congress taking place in Chicago, the United States of America, on 24-27 July 2023. With STIs on the rise, WHO is calling for better access to testing and diagnostic services. At the congress, WHO will also discuss its latest STI research agenda and antimicrobial resistance (AMR) in gonorrhoea.

Subscribe to WHO